Key Highlights

  • Sabra expects annualized cash rent of $53 million, a near‑30% rise from the $41 million received in the prior twelve months.
  • The company settled a $300 million RCA mortgage for $200 million, using the cash to trim its revolving line.
  • Full‑year 2026 Normalized FFO per share is projected between $1.53 and $1.55, reflecting a 7% increase over 2025.
  • Normalized AFFO per share is projected between $1.59 and $1.61, an 8% increase.

Sabra Health Care REIT (NASDAQ: SBRA) announced a portfolio overhaul that will lift its annualized cash rent to $53 million, representing a near‑30% jump from the $41 million collected over the prior twelve‑month period. The move, driven by a full re‑tenanting of 26 properties formerly leased to Avamere, positions the trust for stronger cash flow and supports an upgraded 2026 earnings outlook. Investors view the combination of higher rent, reduced leverage, and a refined asset mix as a catalyst for sustained share price appreciation.

Re‑Tenanting Drives Rent Growth

The re‑tenanting plan assigns 22 of the former Avamere sites to subsidiaries of Cascadia Healthcare, a Pacific Northwest operator with roughly 80 facilities on a pro‑forma basis. The remaining four properties will transition to an existing Sabra tenant, deepening a long‑standing partnership in the skilled‑nursing segment. Together, the new lessees will deliver $53 million in annualized cash rent, a rise of almost 30% versus the $41 million previously received.

The transition is slated for completion in the second half of 2026, with the broader portfolio benefiting from additional rent resets and lease amendments that collectively add more than $9 million of cash NOI on a run‑rate basis. This scaling of cash rent enhances the trust’s ability to meet its operational commitments while supporting higher per‑share earnings.

Mortgage Settlement Shrinks Debt Burden

Sabra and Recovery Centers of America finalized a reduced cash repayment of $200 million, fully extinguishing a $300 million mortgage that originally matured in 2026. The cash from the settlement was applied to the company’s revolving credit facility, trimming net debt and improving leverage. As a result, the share of behavioral‑health assets in annualized cash NOI dropped from 13% to 9%.

These actions reduce exposure to a sector that can be volatile and free up capital for targeted growth in senior‑housing and skilled‑nursing domains.

Guidance Update and Market Reaction

In light of the rent uplift and debt reduction, Sabra lifted its full‑year 2026 guidance. Normalized FFO per share is now expected between $1.53 and $1.55, reflecting a 7% rise versus the prior year, while Normalized AFFO per share is projected between $1.59 and $1.61, an 8% increase. Administrative expenses are anticipated to be about $61 million, including roughly $13 million of stock‑based compensation.

Cash interest expense is set at $104 million, with weighted‑average share counts of 258 million for Normalized FFO and 259 million for Normalized AFFO. Following the announcement, the stock rose, bolstered by sector peers AHR (+2.3%), CTRE (+2.1%) and ARE (+1.0%). The share price now sits near the top of its 52‑week range, underscoring investor confidence.

Upcoming Catalyst

The next milestone will be the completion of the Avamere property transitions, expected in the second half of 2026, which will lock in the projected $53 million cash rent and solidify the trust’s earnings trajectory. Observers will also watch the upcoming mortgage settlement timeline to confirm that the reduced liability remains fully settled, ensuring no further debt service pressures arise. These events will shape Sabra’s ability to sustain its elevated guidance and support continued share price momentum.

Based on the Form 8‑K filed July 21 2026.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.